on 22 Oct 2014
Last Applicant/ Owned by
ENDOCYTE INC.
3000 Kent Avenue, Suite A1-100West Lafayette, Indiana 47906
US
Serial Number
1549193 filed on 25th Oct 2011
Correspondent Address
LAVERY, DE BILLY, LLP
1 Place Ville Marie, Suite 4000Montréal
QUÉBEC
CA
H3B4M4
Trademark usage description
pharmaceutical preparations for the diagnosis and treatment of diseases namely cancer, rheumatoid arthritis, osteoarthritis and atherosclerosis; pharm Read MoreVienna Information
27 . 5 . 1
Letters presenting a special form of writingLettres présentant un graphisme spécial
27 . 5 . 19
Letters overlappingLettres se chevauchant
26 . 1 . 2
EllipsesEllipses
26 . 1 . 3
One circle or ellipseUn cercle ou une ellipse
26 . 1 . 9
Ellipses containing one or more circles or polygons (except 26.1.10 and 26.1.11)Ellipses contenant un ou plusieurs cercles ou polygones (excepté 26.1.10 ou 26.1.11)
25 . 5 . 2
Backgrounds divided into two, horizontallyFonds partagés en deux dans le sens horizontal
26 . 1 . 26
Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées
26 . 2 . 7
Semi-circles, semi-ellipsesDemi-cercles, demi-ellipses
26 . 2 . 24
Segments or sectors of circles or ellipses, semi-circles or semi-ellipses with dark surfaces or parts of surfacesSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses avec surface ou partie de la surface foncée
26 . 15 . 1
SpheresSphères
24 . 17 . 1
Punctuation marksSignes de ponctuation
24 . 17 . 2
DotsPoints
CIPO Classification Code
Nice
CIPO Classification Code
Nice
1549193
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 50 on 10th Jan 2014 | Allowed |
Submitted for opposition 42 on 25th Sept 2013 | Advertised |
Submitted for opposition 26 on 5th Sept 2013 | Approved |
Submitted for opposition 27 on 18th Jul 2013 | Approval Notice Sent |
Submitted for opposition 12 on 12th Dec 2012 | Extension of Time |
Submitted for opposition 22 on 19th Apr 2012 | Search Recorded |
Submitted for opposition 20 on 19th Apr 2012 | Examiner's First Report |
Submitted for opposition 31 on 28th Oct 2011 | Formalized |
Submitted for opposition 1 on 26th Oct 2011 | Created |
Submitted for opposition 30 on 25th Oct 2011 | Filed |